March 6, 2017 Acad, Gov/Utilities Chromatography Licensing, IP, and Legal Mass Spectrometry

908 Devices’ Commercialization of Oak Ridge National Laboratory Technology Honored with Federal Laboratory Consortium Award

03.06.17 Life Sciences, Applied Markets, Safety & Security 908 Devices, a pioneer of analytical devices for chemical and biomolecule analysis, today announced that its efforts to develop, build and launch commercial products based on technology licensed from Oak Ridge National Laboratory (ORNL) have been honored by the Federal Laboratory Consortium for Technology Transfer as an... Read more

March 6, 2017 Licensing, IP, and Legal Liq. Handling & Robotics Microscopy

Abberior Instruments and Leica Microsystems conclude license agreement

Living T cell in suspension acquired with a Leica TCS SP8 STED 3X. 3D reconstruction of confocal and STED stacks clearly shows the gain in resolution by STED. Scale bar: 1 µm. Courtesy of Marco Fritsche, Mathias Clausen, and Christian Eggeling, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, UK. Goettingen... Read more

January 3, 2017 Licensing, IP, and Legal

GE Healthcare to commercialize Rapiscan® outside the US, Canada & Mexico for increased access to heart exams

CHALFONT ST. GILES, UK – 3 January, 2017 – GE Healthcare’s Life Sciences business announced today that it has acquired Rapidscan Pharma Solutions Inc., which has the exclusive rights to produce and sell the pharmacological stress agent Rapiscan® (regadenoson) in territories outside the USA, Canada and Mexico. GE Healthcare’s strong industry presence and existing customer and... Read more

December 20, 2016 Clinical Research/Diagn. Lab Top-10 Licensing, IP, and Legal M&A, Partnerships Uncategorized

Agilent Technologies to Acquire Multiplicom N.V., a Leading European Diagnostics Company with State-of-the-Art Genetic Testing Technology and Products

Agilent fortifies its target-enrichment portfolio through its planned acquisition of Multiplicom N.V. SANTA CLARA, Calif. & NIEL, Belgium–(BUSINESS WIRE)–Dec. 20, 2016– Agilent Technologies Inc. (NYSE:A) and Multiplicom N.V. today announced that they have signed a definitive agreement under which Agilent will acquire Multiplicom, a leading European diagnostics company with state-of-the-art genetic testing technology and products.... Read more

December 15, 2016 Clinical Research/Diagn. Licensing, IP, and Legal M&A, Partnerships

Takara Bio Signs Exclusive License Agreement with Otsuka for the Investigational Cancer Treatment HF10, an Oncolytic Virus

Takara Bio Signs Exclusive License Agreement with Otsuka for the Investigational Cancer Treatment HF10, an Oncolytic Virus Kusatsu/Shiga, Japan — December 15, 2016 — Takara Bio Inc. (Takara) announced today that it has entered into an exclusive license agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka) for co-development and commercialization in Japan of the oncolytic virus... Read more

November 27, 2016 Licensing, IP, and Legal PR/Corporate

GE Healthcare Taps Into $28 Billion Orphaned IP Market With Stake in Pilot Lite Ventures

November 28th 2016 – GE Healthcare has taken a 20% stake in global venture management company Pilot Lite Ventures (PLV), expanding its consulting business as it seeks to tap into an estimated $28 billion global market in unexploited healthcare and wellness R&D, orphaned IP and early-stage technology. GE Healthcare Partners currently offers analytics-based consulting solutions... Read more

November 15, 2016 Bio/Pharma/CRO Licensing, IP, and Legal M&A, Partnerships Product Launch

UC San Francisco and GE Healthcare Launch Deep Learning Partnership to Advance Care Globally

UC San Francisco’s Center for Digital Health Innovation and GE Healthcare today announced a partnership to develop a library of deep learning algorithms – complex problem-solving formulas – that will empower clinicians to make faster and more effective decisions about the diagnosis and management of patients with some of the most common and complex medical... Read more